Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 71,323 | 49,087 | 38,212 | 54,506 | 45,557 |
| Cost of Goods | 15,573 | 13,010 | 14,154 | 30,518 | 21,998 |
| Gross Profit | 55,750 | 36,077 | 24,058 | 23,988 | 23,559 |
| Operating Expenses | 90,821 | 77,429 | 74,799 | 65,446 | 47,491 |
| Operating Income | -34,498 | -41,342 | -50,587 | -40,940 | -22,934 |
| Interest Expense | 8,258 | 9,536 | 8,072 | 4,508 | 7,604 |
| Other Income | -175 | -1,268 | -6,788 | 2,289 | -812 |
| Pre-tax Income | -42,931 | -52,146 | -65,447 | -43,159 | -31,350 |
| Net Income Continuous | -42,931 | -52,146 | -65,447 | -43,159 | -31,350 |
| Net Income | $-42,931 | $-52,146 | $-65,447 | $-43,159 | $-31,350 |
| EPS Basic Total Ops | -6.60 | -12.80 | -31.00 | -31.60 | -129.60 |
| EPS Basic Continuous Ops | -6.62 | -12.70 | -31.09 | -31.54 | -129.60 |
| EPS Diluted Total Ops | -6.60 | -12.80 | -31.00 | -31.60 | -129.60 |
| EPS Diluted Continuous Ops | -6.62 | -12.70 | -31.09 | -31.54 | -129.60 |
| EPS Diluted Before Non-Recurring Items | -6.60 | -12.40 | -27.60 | -32.80 | -129.60 |
| EBITDA(a) | $-26,342 | $-30,680 | $-39,625 | $-35,056 | $-14,224 |